Journal of Molecular Biology
Volume 276, Issue 1, 13 February 1998, Pages 165-176
Journal home page for Journal of Molecular Biology

Regular article
Solution structure of Calmodulin-W-7 complex: the basis of diversity in molecular recognition1

https://doi.org/10.1006/jmbi.1997.1524Get rights and content

Abstract

The solution structure of calcium-bound calmodulin (CaM) complexed with an antagonist, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), has been determined by multidimensional NMR spectroscopy. The structure consists of one molecule of W-7 binding to each of the two domains of CaM. In each domain, the W-7 chloronaphthalene ring interacts with four methionine methyl groups and other aliphatic or aromatic side-chains in a deep hydrophobic pocket, the site responsible for CaM binding to CaM-dependent enzymes such as myosin light chain kinases (MLCKs) and CaM kinase II. This competitive binding at the same site between W-7 and CaM-dependent enzymes suggests the mechanism by which W-7 inhibits CaM to activate the enzymes. The orientation of the W-7 naphthalene ring in the N-terminal pocket is rotated approximately 40 degrees with respect to that in the C-terminal pocket. The W-7 ring orientation differs significantly from the Trp800 indole ring of smooth muscle MLCK bound to the C-terminal pocket and the phenothiazine ring of trifluoperazine bound to the N or C-terminal pocket. These comparative structural analyses demonstrate that the two hydrophobic pockets of CaM can accommodate a variety of bulky aromatic rings, which provides a plausible structural basis for the diversity in CaM-mediated molecular recognition.

Introduction

Calmodulin (CaM) is a ubiquitous Ca2+-binding protein of 148 residues that plays an important role in the Ca2+-dependent signaling pathways of eukaryotic cells Klee and Vanaman 1982, Means et al 1982. A wide range of physiological processes are mediated by CaM through Ca2+-dependent regulation of target enzymes such as myosin light chain kinase (MLCK), CaM-dependent kinases, protein phosphatase calcineurin, phosphodiesterase, nitric oxide synthase, Ca2+-ATPase pumps as well as cytoskeletal structural proteins Means et al 1991, Vogel 1994, James et al 1995. This broad specificity is manifested in the CaM binding regions of these target proteins, which differ significantly in their amino acid sequences. Related to this, a variety of small organic molecules, antagonists with distinct chemical structures have been found to inhibit the CaM-mediated processes by direct interaction with calcium-loaded CaM, Ca2+-CaM (Hait & Lazo, 1986). To understand this broad specificity, detailed structural analyses of Ca2+-CaM complexes with target proteins and small molecules are crucial. Furthermore, such analyses may improve our knowledge of how CaM mediates such calcium signaling processes especially in neural cells and how one can block a specific pathway, that would ultimately lead to therapeutic treatments for abnormal neural signal transduction.

CaM is composed of two domains (N-terminal and C-terminal domains) connected by a flexible linker, and has two EF-hand Ca2+-binding sites in each domain (Nakayama & Kretsinger, 1994). The three-dimensional structures of calcium-free (Ca2+-free) CaM and Ca2+-CaM have already been determined by NMR and X-ray crystallography Zhang et al 1995b, Kuboniwa et al 1995, Finn et al 1995, Babu 1985, Kretsinger et al 1986. A comparison of both forms reveals that Ca2+ binding to apo CaM changes the interhelical angle of the two helices of each EF-hand such that CaM undergoes a transition from the “closed” conformation to the “open” conformation Zhang et al 1995b, Kuboniwa et al 1995. This conformational change results in the creation of a hydrophobic pocket on the surface of each domain Babu 1985, Kretsinger et al 1986, which in turn is essential for CaM to bind target enzymes in a Ca2+-dependent manner Ikura et al 1992, Meador et al 1992, Meador et al 1993.

A number of three-dimensional structures of Ca2+-CaM complexed with peptides from target enzymes have been determined. The first was an NMR structure of the complex with a 26-residue peptide from skeletal muscle (sk) MLCK (Ikura et al., 1992), which was followed by the crystal structures of complexes with a 20-residue peptide from smooth muscle (sm) MLCK (Meador et al., 1992), and a 25-residue peptide from brain CaM kinase IIα (Meador et al., 1993). In each complex, the peptide adopts a helical conformation and the flexible domain linker of Ca2+-CaM allows its domains to clamp the target peptide.

CaM antagonists are frequently used to study Ca2+-CaM-dependent activation of various enzymes. In particular, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) and 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10 H-phenothiazine (trifluoperazine, TFP) have been extensively used for this purpose (Figure 1). Crystal structures of Ca2+-CaM complexed with TFP have been reported by two groups Cook et al 1994, Vandonselaar et al 1994, but their results differed significantly. In the crystal structure reported by Cook et al. (1994), only one TFP molecule was identified binding to the C-terminal hydrophobic pocket of CaM, while the crystal structure reported by Vandonselaar et al. (1994) had four TFP molecules: two of them binding to the hydrophobic pocket in each domain of CaM, respectively, and the other two located in the cleft between the CaM domains. Comparisons show that the orientation of the TFP phenothiazine ring binding to the C-terminal hydrophobic pocket of Ca2+-CaM differs by nearly 180° between the two structures. To further complicate matters, a previous NMR study indicated that two TFP molecules bind to one Ca2+-CaM molecule in solution Klevit et al 1981, Dalgarno et al 1984, Craven et al 1996. The stoichiometry of W-7 binding to Ca2+-CaM is also in a similarly complicated situation. Gel filtration experiments reported that three W-7 molecules bind to Ca2+-CaM with a dissociation constant of 11 μM (Hidaka et al., 1979), whereas a recent NMR study on the interaction of the CaM C-terminal half fragment with N-(8-aminooctyl)-5-iodo-1-naphthalene sulfonamide (J-8), a derivative of W-7, suggested that one J-8 molecule binds to the C-terminal domain with the terminal amino group of J-8 being highly mobile. However, the position and orientation of the J-8 naphthalene ring in the hydrophobic pocket remains unclear (Craven et al., 1996).

In this paper, we report the first three-dimensional structure of Ca2+-CaM complexed with W-7, using heteronuclear multidimensional NMR spectroscopy. The binding site and the orientation of W-7 in each domain of Ca2+-CaM have been clearly defined. Our present structure provides the first view of Ca2+-CaM recognizing a naphthalenesulfonamide derivative. The structural comparison of this structure with other published structures of CaM-peptide and CaM-ligand complexes helps to reveal the basis of diversity in molecular recognition by Ca2+-CaM.

Section snippets

NMR spectral changes and stoichiometry

Given the considerable disagreements in the literature concerning the number of antagonist molecules which bind to a molecule of CaM, we monitored changes in the one-dimensional and NOESY spectra upon addition of W-7 to unlabeled CaM, and in the 15N-1H HSQC and 13C-1H CT-HSQC spectra upon addition of unlabeled W-7 to uniformly 13C/15N labeled CaM. W-7 was titrated up to six equivalents of Ca2+-CaM, during which the W-7 signals were gradually shifted and only one set of W-7 signals was observed.

Sample preparation

W-7 hydrochloride was purchased from Seikagaku Kogyo Co., Ltd and used without further purification. Uniformly 15N- or 15N/13C-labeled recombinant Xenopus laevis CaM was expressed in Escherichia coli and purified to homogeneity as previously described (Ikura et al., 1990a). CaM was dissolved in unbuffered 0.4 ml 95% H2O/5%2H2O or 99.99%2H2O solution containing 0.1 M KCl and 10.6 mM CaCl2. The pH/p2H values of the samples were 6.8 without consideration of the isotope effects. The sample

Acknowledgements

We are grateful to Toichi Takenaka and Hiroyoshi Hidaka for encouragement and support, Claude Klee for kindly providing the Xenopus calmodulin expression system, Frank Delaglio and Dan Garrett for their help in using computer software for NMR data processing and analysis, Ken-ichi Koyama and Masaya Orita for NMR experiments and discussions. This work was in part supported by grants (to M. I.) from Medical Research Council of Canada (MRCC). M. I. is a Howard Hughes Medical Institute

References (59)

  • C.B. Klee et al.

    Calmodulin

    Advan. Protein Chem.

    (1982)
  • R.E. Klevit et al.

    A study of calmodulin and its interaction with trifluoperazine by high resolution 1H NMR spectroscopy

    FEBS Letters

    (1981)
  • R.H. Kretsinger et al.

    Crystal structure of calmodulin

    J. Inorg. Biochem.

    (1986)
  • W. Lee et al.

    A pulsed field gradient isotope-filtered 3D 13C HMQC-NOESY experiment for extracting intermolecular NOE contacts in molecular complexes

    FEBS Letters

    (1994)
  • S. MacNeil et al.

    Calmodulin antagonists of improved potency and specificity for use in the study of calmodulin biochemistry

    Biochem. Pharmacol.

    (1988)
  • A.R. Means et al.

    Regulatory functions of calmodulin

    Pharmac. Ther.

    (1991)
  • K.T. O’Neil et al.

    How calmodulin binds its targetssequence independent recognition of amphiphilic a-helices

    Trends Biochem. Sci.

    (1990)
  • A.G. Palmer et al.

    Sensitivity improvement in proton-detected two-dimensional heteronuclear correlation NMR spectroscopy

    J. Magn. Reson.

    (1991)
  • M. Rance et al.

    Improved spectral resolution in COSY 1H NMR spectra of proteins via double quantum filtering

    Biochem. Biophys. Res. Commun.

    (1983)
  • K. Siivari et al.

    NMR studies of the methionine methyl groups in calmodulin

    FEBS Letters

    (1995)
  • T. Szyperski et al.

    3D Hα/βCα/β(CO)NHN, a projected 4D NMR experiment for sequential correlation of polypeptide 1Hα/β, 13Cα/β and backbone 15N and 1HN chemical shifts

    J. Magn. Reson.

    (1994)
  • G.W. Vuister et al.

    Resolution enhancement and spectral editing of uniformly 13C-enriched proteins by homonuclear broadband 13C decoupling

    J. Magn. Reson.

    (1992)
  • D.S. Wishart et al.

    Chemical shifts as a tool for structure determination

    Methods Enzym.

    (1994)
  • M. Wittekind et al.

    HNCACB, a high-sensitivity 3D NMR experiment to correlate amide-proton and nitrogen resonances with the alpha- and beta-carbon resonances in proteins

    J. Magn. Reson.

    (1993)
  • M. Zhang et al.

    Two-dimensional NMR studies of selenomethionyl calmodulin

    J. Mol. Biol.

    (1994)
  • M. Zhang et al.

    The effect of Met→Leu mutations on calmodulin’s ability to activate cyclic nucleotide phosphodiesterase

    J. Biol. Chem.

    (1994)
  • M. Zhang et al.

    Interaction of calmodulin with its binding domain of rat celebellar nitric oxide synthase

    J. Biol. Chem.

    (1995)
  • J.B. Ames et al.

    Secondary structure of myristoylated recoverin determined by three-dimensional heteronuclear NMRimplications for the calcium-myristoyl switch

    Biochemistry

    (1994)
  • Y.S. Babu

    Three-dimensional structure of calmodulin

    Nature

    (1985)
  • Cited by (145)

    View all citing articles on Scopus
    1

    Edited by P. E. Wright

    b

    Present address: M. B. Swindells and T. Furuya, Helix Research Institute, Kisarazu 292, Japan.

    View full text